Your browser doesn't support javascript.
loading
Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial.
Garcia-Ruiz, Alonso; Macarro, Carlos; Zacchi, Francesca; Morales-Barrera, Rafael; Grussu, Francesco; Casanova-Salas, Irene; Sanguedolce, Francesco; Gonzalez, Macarena; Cresta-Morgado, Pablo; de Albert, Matias; Garcia-Bennett, Josep; Marmolejo, David; Planas, Jacques; Roche, Sarai; Mast, Richard; Zatse, Christina; Piulats, Josep M; Herrera-Imbroda, Bernardo; Regis, Lucas; Agundez, Laura; Olmos, David; Calvo, Nahum; Escobar, Manuel; Carles, Joan; Mateo, Joaquin; Perez-Lopez, Raquel.
Afiliação
  • Garcia-Ruiz A; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Macarro C; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Zacchi F; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain; Section of Innovation Biomedicine-Oncology, Department of Engineering for Innovation Medicine, University of Verona and University and Hospital Trust of Verona, Verona, Italy.
  • Morales-Barrera R; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Grussu F; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Casanova-Salas I; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Sanguedolce F; Fundació Puigvert, Institut de Recerca Sant Pau, Barcelona, Spain; Department of Medicine, Surgery and Pharmacy, Universitá degli Studi di Sassari, Sassari, Italy.
  • Gonzalez M; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Cresta-Morgado P; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain.
  • de Albert M; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Garcia-Bennett J; Bellvitge University Hospital, L'Hospitalet del Llobregat, Spain.
  • Marmolejo D; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Planas J; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Roche S; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Mast R; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Zatse C; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Piulats JM; Bellvitge University Hospital, L'Hospitalet del Llobregat, Spain; Institut Catala d'Oncologia, L'Hospitalet del Llobregat, Spain.
  • Herrera-Imbroda B; Hospital Universitario Virgen de la Victoria and Instituto de Investigación Biomédica de Málaga-Plataforma Bionand, Malaga, Spain.
  • Regis L; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Agundez L; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Olmos D; Hospital Doce de Octubre and Instituto de Investigacion i+12, Madrid, Spain.
  • Calvo N; Bellvitge University Hospital, L'Hospitalet del Llobregat, Spain.
  • Escobar M; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Carles J; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Mateo J; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain. Electronic address: jmateo@vhio.net.
  • Perez-Lopez R; Vall d'Hebron Institute of Oncology, Barcelona, Spain. Electronic address: rperez@vhio.net.
Eur Urol ; 2024 Mar 14.
Article em En | MEDLINE | ID: mdl-38490857
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Urol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Urol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha